caseiris17's Forum Info |
Joined: |
12-25-2022 |
Last Visit: |
(Hidden) |
Total Posts: |
0 (0 posts per day | 0 percent of total posts) |
Total Threads: |
0 (0 threads per day | 0 percent of total threads) |
Time Spent Online: |
(Hidden) |
Members Referred: |
0 |
|
|
Additional Info About caseiris17 |
Bio: |
The Cost-Effectiveness Investigation regarding Nivolumab In addition Ipilimumab Compared to Pembrolizumab Plus Axitinib along with Compared to Adenylosuccinate synthase Plus Axitinib inside First-Line Treatment of Innovative Kidney Cell Carcinoma
http://en.wikipedia.org/wiki/Adenylosuccinate_synthase |
Sex: |
Female |
|